Medical Travel Digital Health News (MTDHN): First, tell our readers why Recuro’s COVID-19 PCR rapid testing is a vital component of every employer’s back-to-work strategy – what are the key issues that employers should be looking at?
The follow up to this discussion is Recuro’s role with the travel industry and why the testing is critical for passengers returning to the U.S.
John Halsey (JH): As employers develop COVID-19 back-to-work strategies for their workforces, they can leverage our discreet apps to create a solution for rapid testing that addresses the challenges.
Specific to COVID-19, we’ve created a systematized way to integrate a physician order for testing, distribution, administration and validating results. When appropriate, even observation and documentation of the specimen collection within a unified context, or in our case an application environment, provides that systematized approach — whether it’s a smartphone device or a web-based interface.
MTDHN: Tell the readers about the solution itself – describe the app.
Michael Brombach (MB): Recuro is enabling the employer’s back-to-work strategy.
Employers are trying to think through how to bring people back to work safely. This is a risk-miss mitigation opportunity: bring the workforce back and do it safely.
Employers want to make everyone comfortable and do so in a manner that is compliant. Our solution enables and empowers all of this – basically with one specific employer activation code for the app.
The process goes as follows:
Continue reading this article on: www.medicaltraveltoday.com